Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University...
-
Upload
james-gardner -
Category
Documents
-
view
225 -
download
3
Transcript of Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University...
![Page 1: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/1.jpg)
Dr Helen Ling
Queen Square Brain Bank for Neurological DisordersInstitute of Neurology
University College London
Clinical aspects of MSA
2nd UK MSA Research Meeting
![Page 2: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/2.jpg)
Possible MSA:Sporadic, progressive, >30y.o.:-Parkinsonism with poor L-dopa response or cerebellar syndrome-Autonomic failure (urinary symptoms/ED or OH)
Probable MSA:Possible + ≥ 1 additional features:
Additional features (probable):Babinski signStridor
MSA-P:Rapidly progressive parkinsonismPoor L-dopa responsePostural instability <3yrs of onsetCerebellar signsDysphagia <5yrs of onsetMRI: atrophy of putamen, pons, cerebellumFDG-PET: hypometabolism in putamen, brainstem, cerebellum
MSA-C:ParkinsonismMRI / FDG-PET findingsDAT-SPECT: reduced uptake
Definite MSA:
![Page 3: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/3.jpg)
MSA-P
‘Red flag’ features supportive of MSA:Rapid progression (wheelchair)
AntecollisL-dopa induced fixed orofacial dystonia
Severe dysarthrophoniaJerky action tremorPolyminimyoclonus
Others:Cold hands, Raynaud’s phenomenon
REM sleep behaviour disorder (early sign)New snoring, sleep apnoea
Inspiratory stridor/sighsPisa syndrome
Emotional incontinence (MSA & PSP)
![Page 4: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/4.jpg)
MSA-C Differential diagnosis:Idiopathic late onset cerebellar ataxia
Spinocerebellar ataxia 2, 3, 6Fragile X premutation (FXTAS)
Primary progressive multiple sclerosis
![Page 5: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/5.jpg)
![Page 6: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/6.jpg)
PAF Premotor MSA
RBD - +
ED + +
UD + +
OH + +
RD/Stridor - +
Smell + - / +
Pure Autonomic Failure Vs. Premotor MSA
![Page 7: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/7.jpg)
Prospective f/u of MSA patients for 2 years:
N = 141 (38% MSA-C); moderately severe
Mixed parkinsonism and cerebellar signs in majority of cases
Mean age of onset = 56.2 years
Median survival = 9.8 years (95% CI 8.1 – 11.4)
Unified MSA Rating Scales (UMSARS)
![Page 8: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/8.jpg)
Prospective f/u of MSA patients for 2 years:
N = 141 (38% MSA-C); moderately severe
Mixed parkinsonism and cerebellar signs in majority of cases
Mean age of onset = 56.2 years
Median survival = 9.8 years (95% CI 8.1 – 11.4)
Unified MSA Rating Scales (UMSARS)
![Page 9: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/9.jpg)
Independent predictors of disease duration in MSA
Milestones of disease progression and total disease course
Early autonomic dysfunctionOlder age of onset
Not admitted to residential care
53% of 83 MSA cases developed autonomic dysfunction within 2
years
![Page 10: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/10.jpg)
MSA ‘Variants’
Classical:MSA-PMSA-C
Long Duration
MSA
Minimal Change
MSA
MSA with Cognitive
Impairment
![Page 11: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/11.jpg)
Case 1 (UK) Case 2 (UK) Case 3 (UK) Case 4 (Canada) Mean
Age at onset 62 50 48 43 50.8
Disease duration 15 17 19 18 17
Initial presentation
Parkinsonism
(Lt hand rest tremor)
Parkinsonism
(Lt hand slowness)
Parkinsonism
(Lt hand rest tremor)
Parkinsonism
(Rt foot and hand tremor)
Latency to autonomic dysfunction
11 years
(UI)
9 years
(UI)
11 years
(UR)
14 years
(OH)11.3
Cerebellar symptoms (latency in years)
No No No Ataxic gait and limbs dysmetria
(14)
“Red flags” latency
(latency in years)
Antecollis (8)
Antecollis (8)
Inspiratory stridor (6)
Dysarthria (10)
Antecollis (9)
Dysphagia (9)
Inspiratory stridor (14)
Dysphagia (16)
Myoclonus (17)
9
I Petrovic, H Ling, Y Asi et al. Mov Disord. 2012
MSA-P with slow progression: A diagnostic catch
![Page 12: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/12.jpg)
Clinical characteristics:
Late onset autonomic dysfunction
All had Ldopa-induced generalised choreiform dyskinesia despite limited motor benefit
MSA-P with slow progression: A diagnostic catch
I Petrovic, H Ling, Y Asi et al. Mov Disord. 2012
Slow progression MSA
Classic MSA
![Page 13: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/13.jpg)
![Page 14: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/14.jpg)
Pathological findings:
• Neuronal loss in substantia nigra & locus coeruleus
• Glial cytoplasmic inclusions - widespread
![Page 15: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/15.jpg)
Y Asi, H Ling, I Petrovic et al. Manuscript under review.
Minimal Change MSA
![Page 16: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/16.jpg)
![Page 17: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/17.jpg)
![Page 18: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/18.jpg)
Case 1 (UK) Case 2 (UK) Case 3 (UK) Case 4 (Canada)
Age at onset 62 50 48 43
Disease duration 15 17 19 18
Cognitive impairment (latency in years)
No NoMCI (12)
Dementia (17)MCI (15)
Petrovic et al. MDJ 2012, Asi and Ling et al, 2014 under review
MSA-P with slow progression:
2 out of 4 cases had cognitive impairment
![Page 19: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/19.jpg)
Summary:
• Diagnostic accuracy of MSA - 75%
• Early autonomic dysfunction and older age of onset are
poor prognostic factors
• A subgroup of MSA-P may have very long disease duration
for up to 19 yrs and autonomic dysfunction only occurs in
the second decade
• Minimal change MSA – a unique subgroup which may
represent early MSA pathology
• Cognitive impairment can be a feature in up to 30% of cases
![Page 20: Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.](https://reader035.fdocuments.us/reader035/viewer/2022081511/56649cff5503460f949d1009/html5/thumbnails/20.jpg)
Acknowledgements
• Janice Holton• Yasmine Asi• Igor Petrovic• Andrew Lees• Niall Quinn• Zeshan Ahmed• Tetsutaro Ozawa• Tamas Revesz• Henry Houlden• John Hardy• Nadia Magdalinou• Atbin Djamshidian• Alastair Noyce
• Sean O'Sullivan• Luke Massey• Linda Parsons• Susan Stoneham• Robert Courtney• Kate Strand• Iliyana Komsiyska• Tammaryn Lashley• Queen Square Brain Bank• Patients and family
Acknowledgements